Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    MyBucks

    MCap

    EUR1m

    Last close

    EUR0.06

    ▲ 0.05 (400.00%)

    MagForce

    MCap

    —

    Last close

    EUR0.02

    ▲ 0.01 (100.00%)

    OpGen

    MCap

    USD7m

    Last close

    USD0.17

    ▲ 0.04 (30.77%)

  • Sectors

    Sectors

  • Investment Strategy

    Investment Strategy

    View All

    Latest

  • Thematics

    Thematics

    View All Thematics

    Latest

Executive interview – PAION at EKF 2019

Executive interview – PAION at EKF 2019

In this interview, Dr James Phillips, CEO of Paion, provides an overview of the company and its focus on anaesthesia products. He explains what differentiates remimazolam from other anaesthetics, how the established clinical data are perceived by key opinion leaders, and what key milestones investors should watch out for in the next 12–24 months. He also discusses how remimazolam is being commercialised in key markets and why the company decided to self-commercialise the drug in the EU.

< Previous
Next >

You may also be interested in these:

TMT

The MISSION Group - executive interview

Investment Companies

Vantage: Paul Sedgwick of Frank Investments gives his insight into running a balanced portfolio

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free